Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.

Source:http://linkedlifedata.com/resource/pubmed/id/21655226

Download in:

View as

General Info

PMID
21655226